Vivos (RDGL) Equity Ratio (2010 - 2025)
Vivos recorded quarterly Equity Ratio of 0.89 in Q4 2025, down 6.48% quarter-over-quarter from 0.95 in Q3 2025, and down 7.5% year-over-year from 0.96 in Q4 2024.
Vivos' Equity Ratio history runs 16 years deep, the most recent figure standing at 0.89 for Q4 2025.
- In Q4 2025, Equity Ratio fell 7.5% year-over-year to 0.89; the TTM figure through Dec 2025 stood at 0.89 (down 7.5% YoY), while the FY2025 annual figure was 0.89, down 7.5% from the prior year.
- Equity Ratio came in at 0.89 for Q4 2025 at Vivos, down from 0.95 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.97 in Q1 2023 to a low of 0.7 in Q3 2021.
- A 5-year average of 0.89 and a median of 0.93 in 2022 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio jumped 2527.79% in 2021 and declined 11.05% in 2023, its largest moves.
- Vivos' Equity Ratio stood at 0.9 in 2021, then advanced by 6.15% to 0.95 in 2022, then decreased by 11.05% to 0.85 in 2023, then increased by 13.39% to 0.96 in 2024, then fell by 7.5% to 0.89 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.89, 0.95, and 0.97 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Vivos | - | - | -3,105.00 | 0.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.89 |
| Sep 30, 2025 | 0.95 |
| Jun 30, 2025 | 0.97 |
| Mar 31, 2025 | 0.97 |
| Dec 31, 2024 | 0.96 |
| Sep 30, 2024 | 0.96 |
| Jun 30, 2024 | 0.91 |
| Mar 31, 2024 | 0.95 |
| Dec 31, 2023 | 0.85 |
| Sep 30, 2023 | 0.93 |
| Jun 30, 2023 | 0.94 |
| Mar 31, 2023 | 0.97 |
| Dec 31, 2022 | 0.95 |
| Sep 30, 2022 | 0.92 |
| Jun 30, 2022 | 0.81 |
| Mar 31, 2022 | 0.93 |
| Dec 31, 2021 | 0.90 |
| Sep 30, 2021 | 0.70 |
| Jun 30, 2021 | 0.73 |
| Mar 31, 2021 | 0.73 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | -15.03 |
| Jun 30, 2020 | -2.62 |
| Dec 31, 2019 | -33.73 |
| Sep 30, 2019 | -6.05 |
| Jun 30, 2019 | -25.51 |
| Mar 31, 2019 | -18.25 |
| Dec 31, 2018 | -57.15 |
| Sep 30, 2018 | -2,957.73 |
| Jun 30, 2018 | -1,307.28 |
| Mar 31, 2018 | -7,426.78 |
| Dec 31, 2017 | -271.55 |
| Sep 30, 2017 | -119.92 |
| Jun 30, 2017 | -40.17 |
| Mar 31, 2017 | -596.01 |
| Dec 31, 2016 | -71.92 |
| Sep 30, 2016 | -283.96 |
| Jun 30, 2016 | -295.18 |
| Mar 31, 2016 | -62.09 |
| Dec 31, 2015 | -56.37 |
| Sep 30, 2015 | -105.15 |
| Jun 30, 2015 | -150.70 |
| Mar 31, 2015 | -266.04 |
| Dec 31, 2014 | -222.73 |
| Sep 30, 2014 | -61.07 |
| Jun 30, 2014 | -31.24 |
| Mar 31, 2014 | -30.57 |
| Dec 31, 2013 | -44.32 |
| Sep 30, 2013 | -16.26 |
| Jun 30, 2013 | -17.46 |
| Mar 31, 2013 | -10.91 |
| Dec 31, 2012 | -8.40 |
| Sep 30, 2012 | -7.18 |
| Jun 30, 2012 | -6.99 |
| Mar 31, 2012 | -5.64 |
| Dec 31, 2011 | -4.33 |
| Sep 30, 2011 | -3.44 |
| Jun 30, 2011 | -2.65 |
| Dec 31, 2010 | -1.12 |